Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess Efficacy and Tolerability of Ketoprofen 40 mg Granules vs Placebo

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Signed Informed Consent Form;~2. Male and female, from 18 years to 65 years (inclusively);~3. Subjects who undergo removal of a non-impacted molar tooth within 3 hours before randomization in the study;~4. Subjects in generally good health (based upon criteria for safe administration of outpatient conscious sedation);~5. Subjects requesting relief for postoperative pain within 3 h after the tooth extraction (VAS ≥30 mm);~6. Subjects willing to undergo observation period for up to 9 hours after the tooth extraction;~7. Ability to complete a 100 mm VAS and a category scale during the observation period (about 9 hours);~8. Full comprehension: ability to comprehend the full nature and purpose of the study, including possible risks and side effects; ability to co-operate with the Investigator and to comply with the requirements of the entire study;~9. Contraception (for females): females of child-bearing potential must be using at least one reliable method of contraception, as follows:~   1. hormonal oral, implantable, transdermal, or injectable contraceptives;~  2. a non-hormonal intrauterine device \[IUD\] or female condom with spermicide or contraceptive sponge with spermicide or diaphragm with spermicide or cervical cap with spermicide; or should have:~  3. a male sexual partner who agrees to use a male condom with spermicide;~  4. a sterile sexual partner.~Exclusion Criteria:~1. Subjects undergoing extraction of impacted and dystopic teeth, tooth preserving operations, apically positioning flap/vestibuloplasty with free gingival graft from the palate;~2. Subjects undergoing more than one tooth extraction in the same extraction procedure;~3. Subjects undergoing dental implantation simultaneously with tooth extraction;~4. Allergy: ascertained or presumptive hypersensitivity to the active substances (ketoprofen and paracetamol as rescue medication) and/or formulations' ingredients; history of hypersensitivity to drugs (in particular to NSAIDs) or allergic reactions in general, which the Investigator considers may affect the outcome of the study;~5. Diseases: relevant history of renal, hepatic, cardiovascular, respiratory (including asthma), skin, haematological, endocrine, gastro-enteric and genitourinary tract or neurological and autoimmune diseases, that may interfere with the aim of the study;~6. Medications: non-steroidal anti-inflammatory drugs (NSAIDS) and other analgesics \[in particular ketoprofen, paracetamol and acetylsalicylic acid (ASA)\], antihistamines, sedating medications, including herbal and BASs, taken 48 h before surgery;~7. Investigational drug trials: participation in the evaluation of any drug within 3 months before screening (including the last study procedure);~8. Relevant history of drug and alcohol abuse.~9. Positive Pregnancy test in female patients of childbearing potential (including patients in post-menopausal status for less than 2 years).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- OKITASK® (Type: EXPERIMENTAL): Single oral administration of Ketoprofen lysine salt 40 mg granules
- Placebo (Type: PLACEBO_COMPARATOR): Single oral administration of placebo matching granules.

Based on this trial design, predict the completion outcome and termination type (if applicable).